Search Within

Jan Philipp Bewersdorf

Formats
  1. Meeting Abstract (40)
  2. Journal Article (26)
  3. Review (21)
  4. Research Letter (7)
  5. Correspondence (4)
  6. Editorial (4)
  7. Guidelines (1)
Groups
  1. GME, Medicine (103)
  2. Graduate Medical Education (103)
  3. Hematology-Oncology Fellows (103)
  4. Center for Hematologic Malignancies (60)
  5. Department of Medicine (60)
  6. Hematologic Malignancies, Division of (60)

More Groups

People
  1. Eytan Stein (33)
  2. Aaron Goldberg (20)
  3. Omar Abdel-Wahab (15)
  4. Andriy Derkach (14)
  5. Raajit Rampal (9)
  6. Maximilian Stahl (5)

More People

Years
  1. 2025 (7)
  2. 2024 (26)
  3. 2023 (42)
  4. 2022 (25)
  5. 2021 (3)
Publications
  1. Blood (41)
  2. Leukemia and Lymphoma (7)
  3. Leukemia (6)
  4. Blood Reviews (5)
  5. Journal of Clinical Oncology (4)
  6. American Journal of Hematology (3)

More Publications

Publishers
  1. American Society of Hematology (43)
  2. Nature Publishing Group (8)
  3. Taylor & Francis Group (8)
  4. American Society of Clinical Oncology (5)
  5. Churchill Livingstone (5)
  6. Elsevier Inc. (4)

More Publishers

Results (103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • E7820, an anti-cancer sulfonamide, in combination with venetoclax in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Meeting Abstract

    Bewersdorf, J. P.; Chandhok, N. S.; Watts, J. M.; Derkach, A.; Abdel-Wahab, O.; Stein, E. M.; Taylor, J.
    Blood (2023)

    Fulltext@MSK | Save
  • E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: A phase II clinical trial
    Research Letter

    Bewersdorf, J. P.; Stahl, M.; Taylor, J.; Mi, X.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Lu, S. X.; Bourcier, J.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
    Review

    Santinelli, E.; Pascale, M. R.; Xie, Z.; Badar, T.; Stahl, M. F.; Bewersdorf, J. P.; Gurnari, C.; Zeidan, A. M.
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
    Review

    Stahl, M.; Bewersdorf, J. P.; Xie, Z.; Porta, M. G. D.; Komrokji, R.; Xu, M. L.; Abdel-Wahab, O.; Taylor, J.; Steensma, D. P.; Starczynowski, D. T.; more...
    Blood Reviews (2023)

    Fulltext@MSK | Save
  • Moving toward disease modification in polycythemia vera
    Journal Article

    Bewersdorf, J. P.; How, J.; Masarova, L.; Bose, P.; Pemmaraju, N.; Mascarenhas, J.; Rampal, R. K.
    Blood (2023)

    Fulltext@MSK | Save
  • Pericytes are protective in experimental pneumococcal meningitis through regulating leukocyte infiltration and blood–brain barrier function
    Journal Article

    Teske, N. C.; Dyckhoff-Shen, S.; Beckenbauer, P.; Bewersdorf, J. P.; Engelen-Lee, J. Y.; Hammerschmidt, S.; Kälin, R. E.; Pfister, H. W.; Brouwer, M. C.; Klein, M.; more...
    Journal of Neuroinflammation (2023)

    Fulltext@MSK | Save
  • SVR (spleen volume reduction) predicts OS (overall survival) in MF (myelofibrosis) patients on PAC (pacritinib) but not BAT (best available therapy): PERSIST-2 landmark OS analysis
    Meeting Abstract

    Ajufo, H.; Bewersdorf, J. P.; Harrison, C.; Palandri, F.; Mascarenhas, J.; Palmer, J.; Gerds, A.; Kiladjian, J. J.; Buckley, S.; Derkach, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • When to use which molecular prognostic scoring system in the management of patients with MDS?
    Review

    Kewan, T.; Bewersdorf, J. P.; Gurnari, C.; Xie, Z.; Stahl, M.; Zeidan, A. M.
    Best Practice and Research: Clinical Haematology (2023)

    Fulltext@MSK | Save
  • Standardising acute myeloid leukaemia classification systems: A perspective from a panel of international experts
    Review

    Shallis, R. M.; Daver, N.; Altman, J. K.; Komrokji, R. S.; Pollyea, D. A.; Badar, T.; Bewersdorf, J. P.; Bhatt, V. R.; de Botton, S.; de la Fuente Burguera, A.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save
  • A phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    Meeting Abstract

    Bewersdorf, J. P.; Verstovsek, S.; Derkach, A.; Masarova, L.; Pemmaraju, N.; Stein, E. M.; Mauro, M. J.; Rampal, R.; Bose, P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save